Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 449, pseudogene (RNU6-449P) is a pseudogene derived from the gene encoding U6 small nuclear RNA (U6 snRNA)[3]. U6 snRNA itself is a highly conserved, non-coding RNA that is an essential component of the spliceosome, the molecular machine responsible for removing introns from pre-mRNA during splicing in eukaryotes[1][3]. The name "pseudogene" indicates that RNU6-449P is a sequence similar to the functional U6 snRNA gene, but is ordinarily *nonfunctional* due to disabling mutations or lack of a promoter, meaning it does not produce a functional RNA or protein product[2][4]. Many U6-derived pseudogenes exist within vertebrate genomes, thought to reflect the evolutionary importance of the functional U6 snRNA gene[3]. While pseudogenes were once seen as "junk" DNA, recent scholarship has shown that some can regulate gene expression as long non-coding RNAs, microRNA decoys, or through other mechanisms; a few are linked to diseases such as cancer, though there is currently no evidence that RNU6-449P itself has such roles[4]. Key clarifications: - RNU6-449P is not a protein, enzyme, transporter, receptor, or classical drug target—**it is a non-coding RNA pseudogene**[3]. - No drugs, clinical biomarkers, or well-studied disease associations are reported for RNU6-449P specifically as of current literature[4]. - Pseudogenes in general may influence gene expression, but each case is specific; there is **no evidence RNU6-449P is a therapeutic target or clinically actionable**[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 449, pseudogene (RNU6-449P).